Atypical protein kinase Ci (PKCi) promotes metastasis of esophageal squamous cell carcinoma by enhancing resistance to anoikis via PKCi-SKP2-AKT Pathway

Molecular Cancer Research

Volumn 9, Issue 4, 2011, Pages 390-402

  Liu, Shu Guang ^a   Wang, Bo Shi ^a   Jiang, Yan Yi ^a   Zhang, Tong Tong ^a   Shi, Zhi Zhou ^a   Yang, Yang ^a   Yang, Yi Ling ^a   Wang, Xiao Chun ^a   Lin, De Chen ^a   Yu, Zhang ^a   Yang, Hai ^a   Cai, Yan ^a   Zhan, Qi Min ^a   Wan, Ming Rong ^a,b  

^a CANCER HOSPITAL   (China)

^b PEKING UNION MEDICAL COLLEGE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; PHOSPHATIDYLINOSITOL 3 KINASE; POLYUBIQUITIN; PROTEASOME; PROTEIN KINASE B; PROTEIN KINASE C IOTA; S PHASE KINASE ASSOCIATED PROTEIN 2; SMALL INTERFERING RNA; UBIQUITIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANOIKIS; ARTICLE; CARCINOGENICITY; CELL INVASION; CELL MIGRATION; CELL MOTILITY; COLONY FORMATION; DOWN REGULATION; ENZYME ACTIVATION; ENZYME INACTIVATION; ENZYME INHIBITION; ENZYME REPRESSION; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; FEMALE; GENE SILENCING; HUMAN; HUMAN CELL; HUMAN TISSUE; LUNG METASTASIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RNA INTERFERENCE; TUMOR GROWTH; TUMOR XENOGRAFT; UPREGULATION;

ANIMALS; ANOIKIS; CARCINOMA, SQUAMOUS CELL; CELL LINE, TUMOR; CELL TRANSFORMATION, NEOPLASTIC; DOWN-REGULATION; ESOPHAGEAL NEOPLASMS; GENE SILENCING; HUMANS; ISOENZYMES; MICE; MICE, NUDE; PROTEIN KINASE C; PROTO-ONCOGENE PROTEINS C-AKT; S-PHASE KINASE-ASSOCIATED PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

MUS MUSCULUS;

EID: 79954567234     PISSN: 15417786     EISSN: 15573125     Source Type: Journal    
DOI: 10.1158/1541-7786.MCR-10-0359     Document Type: Article

References (37)

1. Orringer MB, Marshall B, Iannettoni MD. Transhiatal esophagectomy: clinical experience and refinements. Ann Surg 1999;230:392-400; discussion 400-3.
2. Zhang J, Anastasiadis PZ, Liu Y, Thompson EA, Fields AP. Protein kinase C (PKC) betaII induces cell invasion through a Ras/Mek-, PKC iota/Rac 1-dependent signaling pathway. J Biol Chem 2004; 279:22118-23. (Pubitemid 38679404)
3. Fields AP, Frederick LA, Regala RP. Targeting the oncogenic protein kinase Ciota signalling pathway for the treatment of cancer. Biochem Soc Trans 2007;35:996-1000. (Pubitemid 350206412)
4. Le Good JA, Ziegler WH, Parekh DB, Alessi DR, Cohen P, Parker PJ. Protein kinase C isotypes controlled by phosphoinositide 3- kinase through the protein kinase PDK1. Science 1998;281: 2042-5. (Pubitemid 28475494)
5. Moscat J, Diaz-Meco MT. The atypical protein kinase Cs. Functional specificity mediated by specific protein adapters. EMBO Rep 2000;1:399-403.
6. Eder AM, Sui X, Rosen DG, Nolden LK, Cheng KW, Lahad JP, et al. Atypical PKCiota contributes to poor prognosis through loss of apicalbasal polarity and cyclin E overexpression in ovarian cancer. Proc Natl Acad Sci U S A 2005;102:12519-24. (Pubitemid 41266391)
7. Regala RP, Weems C, Jamieson L, Khoor A, Edell ES, LohseCM, et al. Atypical protein kinase C iota is an oncogene in human non-small cell lung cancer. Cancer Res 2005;65:8905-11. (Pubitemid 41377380)
8. Zhang L, Huang J, Yang N, Liang S, Barchetti A, Giannakakis A, et al. Integrative genomic analysis of protein kinase C (PKC) family identifies PKCiota as a biomarker and potential oncogene in ovarian carcinoma. Cancer Res 2006;66:4627-35.
9. Yang YL, Chu JY, Luo ML, Wu YP, Zhang Y, Feng YB, et al. Amplification of PRKCI, located in 3q26, is associated with lymph node metastasis in esophageal squamous cell carcinoma. Genes Chromosomes Cancer 2008;47:127-36.
10. Scotti ML, Bamlet WR, Smyrk TC, Fields AP, Murray NR. Protein kinase Ciota is required for pancreatic cancer cell transformed growth and tumorigenesis. Cancer Res 2010;70:2064-74.
11. Fujita T, Liu W, Doihara H, Wan Y. Regulation of Skp2-p27 axis by the Cdh1/anaphase-promoting complex pathway in colorectal tumorigenesis. Am J Pathol 2008;173:217-28. (Pubitemid 351947969)
12. Sutterlüty H, Chatelain E, Marti A, Wirbelauer C, Senften M, M̈uller U, et al. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells. Nat Cell Biol 1999;1:207-14. (Pubitemid 129500939)
13. Carrano AC, Eytan E, Hershko A, Pagano M. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27. Nat Cell Biol 1999;1:193-9. (Pubitemid 129500937)
14. Gstaiger M, Jordan R, Lim M, Catzavelos C, Mestan J, Slingerland J, et al. Skp2 is oncogenic and overexpressed in human cancers. Proc Natl Acad Sci U S A 2001;98:5043-8. (Pubitemid 32397079)
15. Signoretti S, Di Marcotullio L, Richardson A, Ramaswamy S, Isaac B, Rue M, et al. Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer. J Clin Invest 2002;110:633-41. (Pubitemid 34988787)
16. Wang XC, Wu YP, Ye B, Lin DC, Feng YB, Zhang ZQ, et al. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma. Mol Cancer Res 2009;7:12-22.
17. Bashir T, Dorrello NV, Amador V, Guardavaccaro D, Pagano M. Control of the SCF(Skp2-Cks1) ubiquitin ligase by the APC/C (Cdh1) ubiquitin ligase. Nature 2004;428:190-3. (Pubitemid 38374316)
18. Wei W, Ayad NG, Wan Y, Zhang GJ, Kirschner MW, Kaelin WG Jr. Degradation of the SCF component Skp2 in cell-cycle phase G1 by the anaphase-promoting complex. Nature 2004;428: 194-8. (Pubitemid 38374317)
19. Wald FA, Oriolo AS, Mashukova A, Fregien NL, Langshaw AH, Salas PJ. Atypical protein kinase C (iota) activates ezrin in the apical domain of intestinal epithelial cells. J Cell Sci 2008;121: 644-54. (Pubitemid 351524163)
20. Jin Z, Xin M, Deng X. Survival function of protein kinase C{iota} as a novel nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanoneactivated bad kinase. J Biol Chem 2005;280:16045-52. (Pubitemid 40616729)
21. Han Y, Wei F, Xu X, Cai Y, Chen B, Wang J, et al. Establishment and comparative genomic hybridization analysis of human esophageal carcinomas cell line EC9706. Zhonghua Yi Xue Yi Chuan Xue Za Zhi 2002;19:455-7.
22. Bourguignon LY, Zhu H, Shao L, Chen YW. CD44 interaction with c- Src kinase promotes cortactin-mediated cytoskeleton function and hyaluronic acid-dependent ovarian tumor cell migration. J Biol Chem 2001;276:7327-36.
23. Li Y, Tondravi M, Liu J, Smith E, Haudenschild CC, Kaczmarek M, et al. Cortactin potentiates bone metastasis of breast cancer cells. Cancer Res 2001;61:6906-11. (Pubitemid 32896517)
24. Feng YB, Lin DC, Shi ZZ, Wang XC, Shen XM, Zhang Y, et al. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma. Int J Cancer 2009;124:578-88.
25. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumor progression. EMBO J 2003;22:2318-23. (Pubitemid 36604971)
26. Luo ML, Shen XM, Zhang Y, Wei F, Xu X, Cai Y, et al. Amplification and overexpression of CTTN (EMS1) contribute to the metastasis of esophageal squamous cell carcinoma by promoting cell migration and anoikis resistance. Cancer Res 2006;66:11690-9. (Pubitemid 46094181)
27. Du XL, Yang H, Liu SG, Luo ML, Hao JJ, Zhang Y, et al. Calreticulin promotes cell motility and enhances resistance to anoikis through STAT3-CTTN-Akt pathway in esophageal squamous cell carcinoma. Oncogene 2009;28:3714-22.
28. Van Duijn PW, Trapman J. PI3K/Akt signaling regulates p27kip1 expression via Skp2 in PC3 and DU145 prostate cancer cells, but is not a major factor in p27kip1 regulation in LNCaP and PC346 cells. Prostate 2006;66:749-60.
29. Reichert M, Saur D, Hamacher R, Schmid RM, Schneider G. Phosphoinositide- 3-kinase signaling controls S-phase kinase-associated protein 2 transcription via E2F1 in pancreatic ductal adenocarcinoma cells. Cancer Res 2007;67:4149-56. (Pubitemid 46815060)
30. Andreu EJ, Lled́ E, Poch E, Ivorra C, Albero MP, Martínez- Climent JA, et al. BCR-ABL induces the expression of Skp2 through the PI3K pathway to promote p27Kip1 degradation and proliferation of chronic myelogenous leukemia cells. Cancer Res 2005;65:3264-72. (Pubitemid 40524610)
31. Xu L, Deng X. Protein kinase Ciota promotes nicotine-induced migration and invasion of cancer cells via phosphorylation of micro- and mcalpains. J Biol Chem 2006;281:4457-66. (Pubitemid 43847877)
32. Baldwin RM, Parolin DA, Lorimer IA. Regulation of glioblastoma cell invasion by PKC iota and RhoB. Oncogene 2008;27:3587-95. (Pubitemid 351793806)
33. Valentijn AJ, Zouq N, Gilmore AP. Anoikis. Biochem Soc Trans 2004;32:421-5.
34. Schneider G, Saur D, Siveke JT, Fritsch R, Greten F, Schmid RM. IKKalpha controls p52/RelB at the skp2 gene promoter to regulate G1- to S-phase progression. Embo J 2006;25:3801-12. (Pubitemid 44300266)
35. Gao D, Inuzuka H, Tseng A, Chin RY, Toker A, Wei W. Phosphorylation by Akt1 promotes cytoplasmic localization of Skp2 and impairs APCCdh1-mediated Skp2 destruction. Nat Cell Biol 2009;11:397-408.
36. Lin HK, Wang G, Chen Z, Teruya-Feldstein J, Liu Y, Chan CH, et al. Phosphorylation-dependent regulation of cytosolic localization and oncogenic function of Skp2 by Akt/PKB. Nat Cell Biol 2009;11:420-32.
37. Mao M, Fang X, Lu Y, Lapushin R, Bast RC Jr, Mills GB. Inhibition of growth-factor-induced phosphorylation and activation of protein kinase B/Akt by atypical protein kinase C in breast cancer cells. Biochem J 2000;352:Pt 2, 475-82. (Pubitemid 32011441)